ArticleScientific reports2022

Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization.

Jae Hui Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.